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Abstract 
AMP-activated protein kinase (AMPK) plays an important role in the regulation of 
glucose and lipid metabolism in skeletal muscle. Many pigs of Hampshire origin 
have a naturally occurring mutation situated in the PRKAG3 gene which encodes a 
muscle-specific isoform of the AMPK γ3-subunit. This mutation results in excessive 
glycogen storage mainly in white glycolytic skeletal muscle and an increased muscle 
oxidative capacity.  
This thesis examined the in vivo effect of the PRKAG3 mutation on skeletal 
muscles in association with exercise. The pigs performed standardised treadmill 
exercise tests before and after a 5-week training period. Muscle samples (m. biceps 
femoris) and blood samples were taken before and after exercise and in the recovery 
phase. Muscle samples from m. masseter, m. biceps femoris, m. semitendinosus and m. 
longissimus dorsi were taken after euthanasia. Glycogen content and its two fractions 
(proglycogen and macroglycogen), enzyme activity, fibre type characteristics and 
expression/phosphorylation of signalling proteins were analysed. Insulin, glucose, 
lactate and free fatty acid concentrations were analysed on the blood samples. 
Compared with non-carriers, carriers of the PRKAG3  mutation had higher 
macroglycogen content in skeletal muscles. At 3 h but not 6 h of recovery 
following exercise, re-synthesis of glycogen, especially of macroglycogen was higher 
in carriers than in non-carriers. The metabolic blood response did not differ 
between the genotypes. Expression of AMPK in muscle was lower in carriers than 
in non-carriers. The increased rate of glycogen synthesis following exercise in 
carriers was correlated with an increased signalling response of Akt and its substrate 
AS160 and a higher activity of hexokinase. This indicated increased glucose influx 
and phosphorylation of glucose, directed towards glycogen synthesis. The carriers 
had a lower percentage and relative area of type IIB fibres in m. biceps femoris and m. 
longissimus dorsi than non-carriers. In m. longissimus dorsi, carriers had a higher 
percentage of type IIAX fibres and higher citrate synthase activity. In conclusion, 
the PRKAG3 mutation influences, mainly the macroglycogen fraction and muscle 
characteristics in exercise-trained pigs, promoting varying degrees of oxidative 
phenotype in muscles with different functions. 
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1  Introduction 
Strong selection for meat quality and quantity has increased the frequency of 
several mutations in the pig (Fujii et al., 1991; Jeon et al., 1999). One of 
these is the mutation in the RN gene, which strongly influences the 
functional and sensory properties of meat. “Rendement Napole” (RN), 
from the French for Napole yield, is a method for estimating the yield of 
cured cooked ham. The existence of a gene affecting Napole yield was first 
suggested by the French meat scientist Naveau (Naveau et al., 1985) and 
later confirmed by Le Roy et al., (1990). The dominant RN
- allele increases 
the glycogen content of pig muscles (Monin & Sellier, 1985; Naveau et al., 
1985), but the glycogen content in heart and liver is unaffected (Monin et 
al., 1992). The RN
- allele has only been found in Hampshire pigs and it is 
likely that the mutation arose in this breed and has increased in frequency 
due to its favourable effects on growth rate and meat content in the carcass 
(Enfält et al., 1997). Meat from RN
- pigs has a low ultimate pH (because of 
post-mortem degradation of the excess glycogen), a reduced water-holding 
capacity and results in a reduced yield of cured cooked ham (Estrade et al., 
1993; Enfält et al., 1997). The muscle of RN
- carriers has a higher water 
content and this is probably why the RN
- pigs are classified as having higher 
lean meat content (Enfält et al., 1997; Le Roy et al., 2000). Lean meat 
content is the proportion of muscle in the total carcass weight of a pig, 
which has been an important selection goal in pig breeding over the last 50 
years.  
No pathological effects of the RN
- mutation have been reported and it 
does not cause glycogen storage disease. Muscle fibres from RN
- carrier pigs 
show up to 70% excess glycogen in both sarcoplasmic and lysosomal 
compartments compared with non-carriers (Estrade et al., 1993). The RN
- 
mutation has been mapped to chromosome 15 (Milan et al., 1995; Mariani 
et al., 1996). The causative mutation has been characterised as a single   10
nucleotide substitution in the PRKAG3 gene, resulting in the non-
conservative arginine to glutamine substitution at amino acid position 220 
(Milan et al., 2000). A second mutation (V224I) at the neighbouring amino 
residue has also been identified in pigs and is associated with an opposite 
effect, low glycogen and high pH compared with the RN
- allele (Ciobanu et 
al., 2001). The PRKAG3 gene encodes a muscle-specific isoform of the 
regulatory γ3-subunit of adenosine monophosphate-activated protein kinase 
(AMPK) (Milan et al., 2000). AMPK is a fuel sensing enzyme that is present 
in most mammalian tissues and responds to shifts in cellular energy levels. 
When activated, AMPK inhibits ATP-consuming pathways and stimulates 
ATP-generating pathways (Hardie et al., 1997). It is known to inhibit 
enzymes involved in the synthesis of glycogen, fatty acid and cholesterol and 
to stimulate glucose uptake, glycolysis and fatty acid oxidation (Kemp et al., 
1999; Ojuka et al., 2000). As AMPK is a key metabolic enzyme, the 
PRKAG3 mutation is expected to influence the regulation of several key 
metabolic processes in the cell. Contraction or exercise increases the use of 
energy in skeletal muscle, which leads to increase in AMP: ATP ratio and 
activates AMPK.  
The pig is an important animal model in many areas of biomedical 
research due to its anatomic and physiological similarities to man (Swindle et 
al., 1988; Almond, 1996). For instance pigs have played a role in exercise 
physiology for over 40 years (Rülcker, 1968). The pigs used in this thesis, 
non-carriers and carriers of the PRKAG3 mutation, were subjected to acute 
and chronic exercise in order to develop a new animal model for studies of 
carbohydrate metabolism. Exercise increases the utilisation of the glycogen 
stores within the working muscle and stimulates AMPK. AMPK is 
considered an important mediator in insulin-independent glucose transport 
in skeletal muscle (Fujii et al., 2000). Thus, using pigs that differed markedly 
in glycogen content before exercise and sampling of blood and muscle 
tissues in connection with exercise allowed detailed studies of the 
interaction between glycogen stores in skeletal muscle and glucose 
metabolism. Another aspect investigated was whether the carriers of the 
PRKAG3  mutation with high glycogen content in their muscles, had 
enhanced muscle ergogenics, since increased glycogen stores in muscle are 
associated with increased exercise capacity in man (Bergström et al., 1967). 
Glycogen in skeletal muscle contains two different fractions, smaller acid-
insoluble proglycogen particles and larger acid-soluble macroglycogen 
particles (Lomako et al., 1991). A previous study, in which only a few pigs 
were included, showed faster re-synthesis of glycogen, especially of 
macroglycogen, in the carriers after exercise (Essén-Gustavsson et al., 2005).   11 
This thesis therefore included a larger number of pigs and examined 
additional factors that may influence glycogen re-synthesis after exercise.  
Since the PRKAG3 mutation was discovered due to meat quality studies, 
most research in this area has concentrated on the cutlet, m. longissimus dorsi. 
This thesis therefore extended the research area by investigating the effect of 
the mutation in some muscles with different functions. M. biceps femoris, a 
skeletal muscle which has been shown to be active during treadmill exercise, 
was one of the muscles investigated.  
The  PRKAG3 m u t a t i o n  i n  p i g s  i s  a s s o c i a t e d  w i t h  a n  a l m o s t  t w o f o l d  
increase in glycogen content in skeletal muscle. However, the mechanisms 
for the high capacity to store glucose as glycogen in these pigs are unknown. 
This thesis therefore examined factors associated with the increased glycogen 
storage in skeletal muscle in pigs with the PRKAG3 mutation.  
 
1.1  Background 
 
1.1.1  AMPK 
AMPK is a heterotrimeric complex that consists of a catalytic α-subunit and 
regulatory  β- and γ-subunits, which are highly conserved in almost all 
eukaryotes (Hardie et al., 1998). Both the α and β-subunits are encoded by 
two genes (α1, α2, β1, β2) and the γ-subunit is encoded by three genes (γ1, 
γ2,  γ3). AMPK is expressed in all mammalian tissue, with some tissue-
specific isoform expression of the regulatory β-and γ-subunits. 
The regulatory γ3-subunit is the main isoform expressed in skeletal 
muscle, particularly fast-glycolytic muscle (Mahlapuu et al., 2004). In 
contrast, expression of the γ1-and  γ2-subunits is widely distributed in 
tissues. The γ-subunit stabilises the catalytic α-subunit of AMPK and is 
necessary for the catalytic activity of AMPK in mammals. Apart from the 
mutations in the γ3 isoform in pigs several mutations have been identified 
within the γ2 isoform in man that cause cardiac hypertrophy, supraventrical 
tachycardia and elevated cardiac glycogen storage associated with Wolff-
Parkinson-White syndrome (Blair et al., 2001; Daniel & Carling, 2002). 
 
1.1.2  Glycogen 
Glycogen is a glycoprotein with elongated and branched polysaccharide 
chains. The glycogen part is built in tiers around a central protein molecule   12
known as glycogenin. The glycogen granule also contains the proteins 
required for glycogen metabolism. Therefore the glycogen granule is not 
merely a storage site for carbohydrates, but also an independent organelle-
like structure referred to as the glycosome (Rybicka, 1996). 
The primary function of glycogen is to provide storage for glucose and 
this takes place mainly in the liver and skeletal muscle. The highest 
concentration of glycogen is found in the liver, but since the skeletal muscle 
has a greater mass, it contains more glycogen. Glycogen can be rapidly 
broken down to control blood glucose level in response to fasting or muscle 
contraction. The energy requirements of the cell, previous glycogen 
content, enzymatic activity and levels of expression/phosphorylation of 
signalling proteins, hormonal stimulation and training status are factors that 
influence how much glucose enters glycogenesis. Once inside the cell, 
glucose is rapidly phosphorylated by hexokinase to form glucose-6-
phosphate and then glucose-1-phosphate is formed by the enzyme 
phosphoglucomutase (Figure 1). The biosynthesis of glycogen involves a 
specific initiation phase since glycogen synthase (GS) can only lengthen an 
existing chain (Manchester et al., 1996). Glycogen synthesis starts with 
uridine-triphosphate (UTP) which reacts with glucose-1-phosphate to form 
uridine-diphosphate glucose (UDP-glucose), a step which is catalysed by 
UDP-glucose pyrophosphorylase. Glycogenin, a self-glycosylating and 
autocatalytic protein then catalyses the addition of a single UDP-glucose by 
a C-1-O tyrosyl linkage at amino acid residue Tyr-194. Thereafter 
glycogenin adds additional UDP-glucose residues to the single glucose 
residue to form an oligosaccharide chain of 8-12 glucosyl units. The 
“primed” glycogenin then works as a substrate for GS and branching 
enzyme (the elongation phase), which extend the oligosaccharide chain to 
form the characteristic branched structure (Lomako et al., 1988; Alonso et 
al., 1995). There are two types of bonds that link glucose units together: α-
1,4 linkages join glucose units in straight linkages, account for 93% of all 
bonds and are formed by GS; while α-1,6 branched linkages account for the 
remaining 7% of bonds and are formed by branching enzyme. At predicted 
maximal size, the glycogen molecule has a diameter of 42 nm and contains 
55000 glucose residues in 12 tiers (Goldsmith et al., 1982). The high density 
of glucose on the outermost tier prevents the addition of more glucose by 
GS (Melendez et al., 1997).  
Glycogenolysis is catalysed by the enzyme glycogen phosphorylase, 
which cleaves α-1,4 glucosyl bonds to form glucose-1-P. Branches have to 
be removed by debranching enzyme, since phosphorylase can only cleave 
off glucosyl units that are joined in a linear way. Muscle glycogen content is   13 
an important energy source that is used during physical exercise and high 
glycogen content is associated with optimal performance in man 
(Bergström, 1967). Decrease in muscle glycogen content during exercise is 
dependent on factors such as exercise intensity, type of exercise and duration 
(Holloszy et al., 1998).  
 
Figure 1. Intracellular fate of glucose. 
A study has shown that branching enzyme activity is twice as high in the 
muscle of carriers of the PRKAG3 mutation, but no differences have been 
observed between carriers and non-carriers concerning GS, phosphorylase 
or debranching enzyme (Estrade et al., 1994). Proteome analyses of m. 
longissimus dorsi in pigs, have shown that an enzyme used in the synthesis of 
glycogen, UDP-glucose pyrophosphorylase, is significantly up-regulated in 
PRKAG3 carriers. The mRNA transcription and activity of UDP-glucose 
pyrophosphorylase is also up-regulated in carriers (Hedegaard et al., 2004).  
 
1.1.3  Proglycogen and macroglycogen 
In recent years it has been suggested that the well-known glycogen 
synthesis model with glycogenin, glycogen synthase, branching enzyme and   14
the substrate UDP-glucose is not adequate to explain glycogen synthesis. 
Instead, a theory claims that glycogen exists in two forms, the smaller 
proglycogen with a molecular weight of 400 kDa and the larger 
macroglycogen with a molecular weight of 10000 kDa (Lomako et al., 1991; 
Lomako et al., 1993; Alonso et al., 1995). These two fractions of glycogen 
are characterised by their number of glucose units and their solubility in 
acid. The synthesis of glycogen from glycogenin to mature glycogen via the 
formation of proglycogen is suggested to be catalysed by three different 
enzyme activities. The first phase in glycogen synthesis is self-glucosylation 
by glycogenin. Thereafter, proglycogen is formed by proglycogen synthase 
and finally macroglycogen is synthesised by macroglycogen synthase (Figure 
2). Whether proglycogen and macroglycogen are actually distinctly different 
kinds of glycosomes or whether they simply differ on the basis of the size of 
the actual glycogen molecule is unclear (Marchand et al., 2002; Shearer & 
Graham, 2004). Acid separation of glycogen into two fractions is of use to 
separate smaller and larger glycogen granules, which is of significance since 
the size of the glycogen granules has an impact on the rate of synthesis, 
degradation and also sensitivity to carbohydrate supplementation (Adamo et 
al., 1998; Graham et al., 2001; Battram et al., 2004). Interestingly, the 
macroglycogen fraction in humans and rats is reported to increase with high 
muscle glycogen concentrations (Jansson et al., 1981; Derave et al., 2000). 
The re-synthesis of glycogen has been shown to occur mainly in the 
macroglycogen pool in man, when the total glycogen concentration in the 
muscle reaches a concentration of over 300-350 mmol glucosyl units/kg dw 
(Jansson et al., 1981; Adamo et al., 1998). A previous study of few pigs with 
the  PRKAG3 mutation indicated that the carriers had higher 
macroglycogen stores in m. biceps femoris at rest  than the non-carriers. 
Glycogen degradation during treadmill exercise did not differ between the 
genotypes, but the re-synthesis of macroglycogen was faster in the early 
recovery period in the carriers (Essén-Gustavsson et al., 2005). Exercise 
performance on a treadmill was not affected by the high glycogen content in 
the carriers.    15 
 
Figure 2. The proposed model of biogenesis of glycogen. Glycogenin autocatalytically adds 
glucose from UDP-glucose to its tyr-194 and then an average of 7 residues to form a fully 
glucosylated glycogenin that serves as a primer for the synthesis of proglycogen by 
proglycogen synthase and branching enzyme. Proglycogen was suggested to be a stable 
intermediate in the synthesis of mature glycogen (Macroglycogen). The priming chain of 8 
glucose residues corresponds to the average length of elongation but in actuality ranges from 
7 to 11 glucose residues (Lomako et al. 1993). 
 
1.1.4  Glucose metabolism 
Glycogen is one of the major fuel sources used during exercise and in order 
to be able to re-synthesise glycogen, glucose is needed. Glucose is taken up 
from the blood but cannot penetrate the lipid bilayer without a carrier 
protein (due to the hydrophilic nature of glucose). A total of 12 facilitative 
transporters (GLUT1-12) have been identified (Joost et al., 2002) and in 
skeletal muscle insulin-sensitive GLUT4 is the major transporter (Birnbaum, 
1989). GLUT4 translocates from an intracellular compartment to the cell 
surface in response to either insulin or exercise (Douen et al., 1990). 
Insulin signalling 
Insulin-sensitive tissues express insulin receptors at the cell surface, which 
allows them to regulate metabolism through a specific insulin signalling   16
cascade. The insulin signalling events start by insulin binding to the insulin 
receptor (IR) and autophosphorylation of IR tyrosine kinase, causing 
tyrosine phosphorylation of insulin receptor substrates (IRS) 1-4 (both IRS-
1 and IRS-2 are expressed in skeletal muscle) and activation of 
phosphatidylinositol 3-kinase (Alessi et al., 1997; White, 1998). One of the 
downstream pathways by which insulin-stimulated phosphatidylinositol 3-
kinase (PI 3K) activity leads to GLUT4 translocation involves activation of 
the serine/threonine kinase PKB/Akt. There is evidence that Akt functions 
downstream of PI 3K (Kohn et al., 1996) and mediates insulin signalling to 
glucose transport (Cho et al., 2001). At present there are three known 
isoforms of Akt (Akt 1-3) but only Akt 1 and Akt 2 are expressed in skeletal 
muscle (Cho et al., 2001). It has been shown that Akt 1 and Akt 2 have 
different downstream metabolic regulation, in that Akt 1, together with 
IRS-2, is important for lipid metabolism, while Akt 2 and IRS-1 are 
essential for glucose metabolism (Bousakri et al., 2006). Once activated, Akt 
phosphorylates downstream substrates such as the Akt substrate of 160 kDa 
(AS 160). AS 160 is activated and redistributed to the plasma membrane 
following phosphorylation of Akt (Kane et al., 2002). In adipocytes AS160 
mediates insulin-stimulated Akt signalling to glucose transport probably by 
regulation of GLUT4 endocytosis (Sano et al., 2003). AS 160 is also 
expressed in the rat skeletal muscle and phosphorylated in response to 
insulin and contraction (Bruss et al., 2005). In addition to glucose transport 
Akt mediates the effect of insulin on glycogen synthesis via glycogen 
synthase kinase 3 (GSK-3) phosphorylation, which decreases its inhibitory 
effect on glycogen synthase (Cross et al., 1995). This leads to increased 
glycogen synthesis (Figure 3).   17 
 
Figure 3. Insulin- and exercise signalling mechanisms to stimulate glucose transport involve 
GLUT4 translocation. 
Exercise signalling 
Exercise or muscle contraction can also promote glucose transport in skeletal 
muscle (Holloszy & Kohrt, 1996) but the mechanism is less well 
documented than the insulin signalling mechanism. Several studies have 
shown that insulin- and exercise-induced glucose uptake is activated 
through two separate pathways. There is evidence that a maximally effective 
insulin concentration in combination with contractile activity stimulates 
glucose transport (Zorzano et al., 1986; Wallberg-Henriksson et al., 1988), 
and GLUT4 translocation (Lund et al., 1995) to a greater degree than either 
stimulus alone and that the times when glucose uptake occurs are different 
(Wallberg-Henriksson et al., 1987). Wortmannin, a PI 3-kinase inhibitor, 
prevents insulin-mediated, but not contraction-mediated glucose transport 
(Lee et al., 1995) and translocation of GLUT4 (Lund et al., 1995) in isolated 
skeletal muscle. Exercise and insulin-sensitive GLUT4 pools may exist 
(Douen et al., 1990). Exercise/muscle contraction is not sufficient to activate 
IR (Goodyear et al., 1995), IRS1 (Goodyear et al., 1995) or Akt (Brozinick 
& Birnbaum, 1998; Widegren et al., 1998). Recent studies have suggested 
that the two signalling pathways may converge at the point of AS160 and 
that their effects can be added (Kramer et al., 2006). A single session of   18
exercise and also exercise training result in improved insulin sensitivity in 
skeletal muscle (Richter et al., 1982; Wallberg-Henriksson et al., 1987). A 
number of exercise-responsive molecules have been proposed as possible 
candidates for exercise-responsive glucose uptake including nitric oxide 
(Roberts et al., 1999), Ca
2+/calmodulin-dependent protein kinases (Wright 
et al., 2004) and AMPK (Fujii et al., 2000).  
Intracellular fate of glucose 
Once glucose has entered the cell it is rapidly phosphorylated to glucose 6-
phosphate (G-6-P) by hexokinase (HK) and then stays trapped. G-6-P can 
either be converted to glycogen or transferred in the glycolysis pathway to 
pyruvate. The fate of glucose is mainly determined by the energy 
requirement of the cell. ATP and creatine phosphate are the most rapidly 
accessible energy fuels. Muscle glycogen, triglycerides, blood-borne glucose 
and fatty acids are other energy resources. Fatty acids are metabolised to 
acetyl-CoA by mitochondrial enzymes responsible for beta-oxidation, one 
of which is 3-OH-acyl-CoA-dehydrogenase (HAD). For short-term 
exercise the muscle cells rapidly metabolise glycogen to pyruvate 
(glycolysis). Pyruvate can either be metabolised aerobically in the citric acid 
cycle where citrate synthase (CS) is the first key enzyme or anaerobically to 
lactate, by lactate dehydrogenase (LDH). The muscle cell can shuttle the 
lactate into a neighbouring fibre within the same muscle or into the blood, 
where it can be used as a fuel by the heart or another tissue. Lactate is also 
an important precursor to gluconeogenesis in the liver. Aerobic metabolism 
is sufficient to meet the energy demand when oxygen is adequate and the 
muscle is working with low intensity. If contraction proceeds faster and 
with high intensity, oxygen becomes limiting and then the muscle has to use 
the rapid anaerobic glycolytic pathway to supply energy. 
Studies of carriers of the PRKAG3 mutation have shown that they have 
increased oxidative capacity in the m. longissimus dorsi. (indicated by higher 
CS activity) (Estrade et al., 1994; Lebret et al., 1999) and decreased 
glycolytic capacity (indicated by lower LDH activity) (Lebret et al., 1999). 
No significant differences have been found between heterozygous and 
homozygous carriers of the RN
- allele except for the observation that the 
CS activity is lower in the RN
-/rn
+ than in the RN
-/RN
- (Lebret et al., 
1999). The expression patterns of enzymes related to glycolysis and the citric 
acid cycle, such as phosphofructokinase (PFK), the β-subunit of ATP-
specific succinyl-CoA synthetase and mitochondrial aldehyde 
dehydrogenase, have also been shown to be up-regulated by the mutation in 
m. longissimus dorsi of pigs (Hedegaard et al., 2005).    19 
 
1.1.5  Skeletal muscle fibre characteristics  
Skeletal muscle is the largest tissue in the body and is responsible for most 
types of body movement. Over 90% of the muscle consists of the muscle 
fibres. The muscle cell is a multinucleated elongated cell (fibre), and its 
diameter varies both within and between muscles, the size being affected by 
growth and activity. The fibre can contract since it is innervated by neurons 
from the spinal cord. Different histochemical staining techniques can be 
applied to visualise biochemical properties such as enzyme, glycogen and 
lipid levels in individual muscle fibres (Figure 4).   20
 
Figure 4. Histochemical stains for A. myosin ATPase after preincubation at 4.6, B. 
Immunohistochemical stains for A4-74, C. NADH-tetrazolium reductase, D. PAS. The 
muscle sample is obtained from m. biceps femoris of a non-carrier pig.  
Through such methods, it has been demonstrated that skeletal muscle is 
composed of a mixture of fibre types with different contractile and 
metabolic properties. In most animals, glycogen is found at rest in all fibres, 
but glycogen can decrease within the fibres depending on the recruitment of 
the fibres with exercise. Fibre type composition and the physical activity 
level of the muscle are factors that may contribute to the differences seen in 
glycogen content and enzyme activity between muscles. Most skeletal   21 
muscles contain a mixture of different fibre types but in certain species e.g. 
rodents, individual muscles mostly consist of one particular fibre type. Fibre 
types are commonly divided into two major groups; slow-twitch (type I) 
and fast twitch (type II). Type II fibres can further be sub grouped into type 
IIA and IIB fibres by using myosin ATPase staining technique following 
acid and alkali preincubations (Brooke & Kaiser, 1970). Myosin ATPase 
staining studies have revealed that muscles of the pig mostly show an 
organised pattern and unique distribution of different fibre types consisting 
of islets of type I fibres immediately surrounded by type IIA and more 
peripherally by type IIB fibres (Figure 4). The fibres contain different 
myosin heavy chains isoforms that are responsible for their different myosin 
ATPase activities and speeds of contraction. Type I fibres are usually 
involved in low intensity training and rely on oxidative metabolism of lipids 
and carbohydrates for their energy supply. Type II fibres are recruited in 
more intense exercise and depend to a great extent on utilisation of 
carbohydrate and lactate. Another method of characterising fibre types is to 
use myosin heavy chain (MHC) antibodies that identify the different MHC 
isoforms MHC I, MHC IIA MHC IIX and MHC IIB. 
Immunohistochemistry makes it possible to detect hybrid fibres, i.e. fibres 
that contain more than one MHC isoform, which may be an indication that 
fibres are under transformation. Type II fibres can be divided into three 
classes depending on their different MHC isoforms; IIA, IIB and IIX, where 
type IIA is fast fatigue resistant, IIB is fast fatigable, and IIX elicits an 
intermediate fatigue response (Schiaffino et al., 1989). The classification is 
different in different species. The IIB isoform was previously only 
considered to be present in small animals such as mouse, rat, guinea pig and 
rabbit (Bär & Pette, 1989; Schiaffino et al., 1989). However more recent 
studies have shown that pigs also exhibit IIB fibres, mostly in their glycolytic 
muscles (Lefaucheur et al., 1998; Lefaucheur et al., 2002; Tonioli et al., 
2004). Myosin heavy chains can be transformed following a compulsory 
pathway: I↔IIA↔IIAX↔IIX↔IIB, although the shift is reversible 
(Schiaffino & Reggiano, 1994; Pette & Staron, 2000). The pig is a meat 
producing animal, which has been selected and fed to increase muscle 
development, and this has resulted in a fibre-type shift toward type II 
(Solomon & West, 1985; Weiler et al., 1995). In contrast, endurance 
exercise training has been shown to shift the fibre type towards type I in rats 
(Green et al., 1984) and in man (Baumann et al., 1987). Studies in pigs also 
indicate that training may cause fibre-type shifts from type IIB (ATPase 
method) to IIA (Essén-Gustavsson et al., 1993; Petersen et al., 1998). 
Oxidative capacity is known to increase with training and among fibre types 
oxidative metabolism is high in type I fibres and decreases in the order type 
I > type IIA > type IIX > type IIB fibres (Lefaucheur et al., 2002). 
Interestingly wild boars have been shown to have higher oxidative capacity,   22
a higher proportion of type IIA fibres and larger mean fibre area compared 
with domestic pigs (Karlström, 1995) 
It has previously been shown that the m. longissimus dorsi is more 
oxidative in pigs with the PRKAG3 mutation, as indicated by increased CS 
and HAD activity, decreased LDH activity, higher relative area of oxidative 
type IIA fibres and lower relative area of non-oxidative type IIB fibres 
(Lebret et al., 1999). In contrast in m. semispinalis capitis (mostly type I fibres), 
there is no influence of the PRKAG3 mutation on enzyme activity. 
 
1.1.6  Exercise response and adaptation 
Different types of exercise are associated with a dissimilar response and 
adaptation in different muscles. This is related to the fact that skeletal 
muscles consist of different fibre types with different metabolic 
characteristics and fibre recruitment patterns. The effects of exercise on 
muscle characteristics are also specific to the frequency and duration of the 
exercise performed. This makes it often difficult to compare exercise studies 
since they often differ in one of these aspects. In the present study, pigs 
performed a standardised exercise protocol by trotting on a large animal 
treadmill. This type of endurance training has previously been shown to 
affect m. biceps femoris, generating increased glycogen content and improved 
oxidative capacity (Essén-Gustavsson  et al., 1988) whereas no alterations 
were observed in m. longissimus dorsi and m. semitendinosus (Essén-Gustavsson 
& Lindholm, 1983; Essén-Gustavsson et al., 1988). M. longissimus dorsi 
contains a large proportion of type II fibres especially type IIB fibres (80-
90%) and has a low oxidative capacity (Essén-Gustavsson et al., 1980; 
Karlsson et al., 1993). The white portion of m. semitendinosus shares many 
fibre characteristics with m. longissimus dorsi, i.e. a high proportion of type 
IIB fibres and low oxidative capacity (Essén-Gustavsson et al., 1980). M. 
biceps femoris has a lower proportion of type IIB fibres (60-70%) and a higher 
oxidative capacity (Essén-Gustavsson et al., 1980; Karlsson et al., 1993). M. 
masseter is a muscle which is mainly active during the chewing process and 
has a high proportion of type I fibres (around 90%), almost no type IIB 
fibres and a high oxidative capacity (Karlström, 1995).    23 
2  Aims of the thesis 
The overall aim of this thesis was to study the effect of exercise on skeletal 
muscles in pigs with the PRKAG3 mutation, especially the glycogen 
degradation and re-synthesis. 
 
Specific aims were: 
  To study the in vivo effect of the PRKAG3  mutation on the 
expression and phosphorylation of proteins involved in insulin 
and/or contraction induced signalling pathways in skeletal muscle. 
This was to be investigated at rest, after acute exercise, in the 
recovery phase and after a training period. 
  To study the in vivo effect of the PRKAG3 mutation on metabolic 
blood parameters at rest, after acute exercise and in the recovery 
phase in trained pigs. 
  To study the in vivo effect of the PRKAG3 mutation on muscle 
characteristics after a training period. 
  To study the in vivo effect of the PRKAG3  mutation on 
proglycogen and macroglycogen stores in skeletal muscle at rest, 
after acute exercise, in the recovery phase and after a training 
period. 
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3  Aspects of materials and methods 
A brief presentation of the materials and methods used in Papers I-IV is 
given here (Figure 5). A complete description is presented in the individual 
papers. 
 
3.1  Animals  
Sixteen clinically healthy female pigs (Yorkshire/Swedish Landrace x 
Hampshire) from the SLU university herd were used. The pigs were 9-11 
weeks old, had a mean weight of 29 ± 2.5 kg when they arrived, and were 
stalled at the Department of Clinical Sciences, SLU. Eight pigs were 
heterozygous carriers and eight pigs were non-carriers of the PRKAG3 
mutation, as verified by DNA analyses of blood (Milan et al., 2000). The 
pigs were housed in pens (4 pigs/pen) with a concrete floor with straw as 
bedding. The animals were fed a commercial finisher diet without growth 
promoters (Piggfor®; Origio 522 PK, Lantmännen, Uppsala, Sweden) ad lib 
and had free access to water. The pigs were inspected daily for their clinical 
state of health. The experiments were approved by the Ethical Committee 
for Animal Experiments, Uppsala, Sweden. 
 
3.2  Study design 
The studies were conducted during a nine-week period and started with a 
two-week period of acclimatisation. During this period the pigs were 
allowed to walk and trot on a large animal treadmill (Säto, Knivsta, Sweden) 
for a few minutes on four successive days. After acclimatisation, the pigs 
were anaesthetised and muscle biopsy specimens were taken from the   26
middle part of the right m. biceps femoris at a depth of 3-4 cm using a needle 
biopsy technique (Bergström, 1962) (Papers I, IV). The muscle specimens 
were immediately frozen in liquid nitrogen and stored at -80° C until 
analysis. Anaesthesia was achieved by administration of a combination of 
medetomidine (Domitor®vet 1mg/mL; Orion Pharma AB, Stockholm, 
Sweden) and tiletamine and zolazepam (Zoletil®; 250 mg tiletamine + 250 
mg zolazepam/mL; Reading, Carros, France). The final mixture contained 
1 mg/mL medetomidine and 100 mg/mL tiletamine-zolazepam and was 
given at a dosage of 0.05 mL/kg bw.  
Three days after the resting biopsies had been taken, all pigs ran 700 m 
on the treadmill at a speed of 1.5 m/s. Within 10 minutes of 
completion of exercise, the anaesthetic mepivacaine (Carbocain® adrenaline 
20mg/mL + 5µg/mL; Astra Zeneca AB, Södertälje, Sweden) was 
administered locally and a biopsy specimen was obtained from the left m. 
biceps femoris (Paper I, IV). The pigs were restrained at the front of the 
treadmill using a board to enable biopsy specimens to be collected. After 
three hours of recovery, a new biopsy from right the m. biceps femoris was 
collected under anaesthesia (see above) (Papers I, IV).  
The pigs were then trained on the treadmill once daily, five days a week 
for the next five weeks. The speed was gradually increased from 1.5 m/s to 
2.5 m/s and the distance from 300 m to 1000 m. A distance test was 
performed where all pigs were given the opportunity to trot on the 
treadmill until fatigue in the last week of training (week 8). The pigs ran 0-
200 m at a speed of 2.1 m/s, 200-400 m at a speed of 2.3 m/s and 400 m to 
an individual terminal point at 2.5 m/s (Paper IV). Finally, the training 
period ended with a second exercise test where the pigs ran 1000 m on the 
treadmill (0 to 200 m at a speed of 2.1 m/s, 200 to 400 m at a speed of 2.3 
m/s and 400 to 1000 m at a speed of 2.5 m/s). Muscle biopsy specimens 
were collected (after application of local anaesthetic) from the left m. biceps 
femoris within 10 minutes of completion of exercise (Paper IV). After 3 
hours of recovery the pigs were anaesthetised and muscle tissue samples 
were obtained from the right m. biceps femoris (see above) (Papers IV).  
Thereafter the pigs had an indwelling catheter inserted into the jugular 
vein under general anaesthesia, in order to facilitate frequent blood 
sampling. Fifteen minutes prior to induction of anaesthesia, atropine 
sulphate (Atropin®; NM Pharma AB, Stockholm, Sweden) was given i.m. 
at a dosage of 0.05 mg/kg bw. Anaesthesia was then induced with a 
combination of medetomidine and tiletamine/zolazepam at a dosage of 0.05 
mL/kg bw. The animals were then intubated and general anaesthesia was 
maintained by isoflurane, with oxygen and nitrogen monoxide. The surgical 
procedure has been described previously (Rodrigues & Kunavongkrit,   27 
1983). The catheter was brought through a subcutaneous tunnel to the back 
between the scapulas. After being exteriorised, the catheter was put in a 
pocket made of canvas on the dorsal aspect of the pig neck. The pocket was 
fixed at several points with steel sutures. The catheter was cut off to a 
suitable length and was flushed twice a day with saline and heparin solution 
(5000 IU heparin in 0.9% NaCl). The antibiotic, procaine benzylpenicillin 
(Etacilin®; Intervet AB, Stockhom, Sweden) was administered at 20 mg/kg 
i.m. on the day of surgery and the two following days. The regular feeding 
regime was restored immediately after recovery from anaesthesia. After 
insertion of the jugular catheter, the pigs were kept in individual pens 
within sight and sound of one other. Eight days later, a third exercise test 
was performed (using the same exercise protocol as the second exercise test) 
and tissue samples from the left m. biceps femoris were taken within 10 
minutes of completion of exercise (Papers II, IV) and from the right m. 
biceps femoris after 6 hours of recovery (Papers II, IV). In addition, blood 
samples were taken from the indwelling jugular catheter before exercise, 
immediately after the pigs stopped exercising and then after 10 min, 30 min, 
1 h, 2 h, 3 h, 4 h, 5 h and 6 h of recovery (Paper II).  
The pigs were then 18 to 20 weeks old and the carriers had a mean 
weight of 80 ± 1.5 kg and the non-carriers a mean weight 74 ± 3 kg, with 
no significant difference between the two genotypes. 
One week later, tissue samples were taken from m. biceps femoris,  m. 
longissimus dorsi,  m. masseter and m. semitendinosus by excision, after the 
animals had been euthanised by an intravenous overdose of pentobarbital 
(100 mg/mL) (Paper III). Two pigs were withdrawn from the study after 
training, one due to unwillingness to run on the treadmill and the other did 
not survive anaesthesia.   28
 
 
Figure 5. An overview of muscle samples and blood samples obtained in the thesis.  
3.3  Muscle samples 
Muscle biopsy specimens (about 2x1x1 cm) were obtained from m. biceps 
femoris at a depth of 3-4 cm. Muscle specimens were also obtained from m. 
biceps femoris, m. masseter, m. semitendinosus (white portion) and m. longissimus 
dorsi (caudal to the last rib) from the centre of the middle part of the muscle 
within 10 minutes of death. The tissue samples were immediately frozen in 
liquid nitrogen and stored at -80°C until analysis. The tissue samples used 
for histochemistry were rolled in talcum powder before being frozen. 
 
3.3.1  Western Blot (Papers I, II) 
Muscle biopsies were freeze-dried overnight and then muscle tissue was 
dissected out under a microscope to remove visible blood, fat and 
connective tissue. Samples were subsequently homogenised in ice-cold 
homogenisation buffer containing 20 mM Tris (pH 7.8), 137 mM NaCl, 
2.7 mM KCl, 1 mM MgCl2, 1% Triton X-100, 10% (w/v) glycerol, 10 
mM NaF, 1 mM ethylenediaminetetraacetic acid (EDTA), 5 mM Na-
pyrophosphate, 0.5 mM Na3V04, 1 µg/mL leupeptin, 0.2 mM 
phenylmethyl sulphonyl fluoride, 1 µg/mL aprotinin, 1 mM dithiothreitol   29 
(DTT), 1 mM benzamidine and 1 µM microcystin. The homogenised 
samples were then rotated for 30 min at 4º C and thereafter subjected to 
centrifugation (12 000g for 15 min at 4ºC). Protein concentration in the 
supernatant was determined using BCA protein assay kit (Pierce, Rockford, 
IL, USA). Phosphorylation of protein kinases was determined by 
immunoblot analysis. Skeletal muscle protein lysate (40 µg) was separated by 
SDS-PAGE (7.5% resolving gel), transferred to PVDF membranes and 
blocked with 7.5% non-fat milk in TBS-T for two hours at room 
temperature. Membranes were incubated with primary antibodies: anti-
pGSK3  α/β Ser
21/9, pAS160, AS160, Akt, pAkt Thr
308, pAkt Ser
473, 
panAMPKα and pAMPK Thr
172 (Cell Signaling Technology; Boston, MA), 
GLUT4, Na
+-K
+-ATPase α2-subunit and pacetyl-CoA carboxylase (pACC) 
Ser
79(Upstate/ Millipore Corporate Headquarters; Billerica, MA), glycogen 
synthase (gift from Prof. Erik Richter, Copenhagen University), overnight 
at 4ºC on a shaking platform. Thereafter, membranes were washed with 
TBS-T and incubated with appropriate anti-rabbit or anti-mouse secondary 
antibody. Samples from pigs with or without the PRKAG3 mutation were 
included and analysed on the same gel in parallel. Proteins were visualised 
by enhanced chemiluminescence (ECL, Amersham, Little Chalfont, 
Buckinghamshire, UK) and quantified by densitometry and molecular 
analyst software (Bio-Rad, Richmond, CA, USA). All membranes were 
normalised for loading with glyceraldehyde-3-phophate dehydrogenase 
(GAPDH; Santa Cruz Biotechnology, Santa Cruz, CA, USA). 
 
3.3.2  Enzyme activity (Papers I, III) 
Muscle biopsies were freeze-dried overnight and then muscle tissue was 
dissected out under a microscope to remove visible blood, fat, and 
connective tissue. To determine the activity of citrate synthase (CS), 3-
hydroxyacyl-CoA dehydrogenase (HAD), lactate dehydrogenase (LDH), 
hexokinase (HK), and phosphorylase, 1-2 mg of pure tissue was 
homogenized with an ultrasound disintegrator (Branson) in ice-chilled 
potassium phosphate buffer (0.1 M, pH 7.3) at a dilution of 1:400 and then 
analysed fluorometrically (Lowry & Passoneau, 1973). Glycogen synthase 
(GS) activity was determined by a modified method by Thomas et al., 
(1968), based on incorporation of 14C UDPG into glycogen. The active 
form of GS activity was measured at a low concentration (0.3mM) and the 
total activity at a high (6.0mM) concentration of glucose-6-phosphate. 
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3.3.3  Glycogen (Papers I-IV) 
For glycogen determination, 1-2 mg of pure tissue was boiled in 1 M HCl 
for 2 h to form glucose residues. Glucose was analysed by a fluorometric 
method (Lowry & Passoneau, 1973).  
 
3.3.4  Proglycogen and macroglycogen (Paper IV) 
Fractions of proglycogen and macroglycogen were separated on the basis of 
solubility in PCA, using the method described by Adamo & Graham (1998). 
In brief, 200 µL of ice-cold 1.5M PCA were added to 1.5 mg of freeze-
dried muscle specimens. The extraction of macroglycogen into the PCA 
continued for 20 min on ice. After centrifugation at 4000 rpm and 4ºC for 
10 min, 100 µl of the supernatant was removed and used for analysis of 
macroglycogen. The remaining supernatant was used for analyses of glucose, 
glucose-6-phosphate and lactate and the pellet was used for analysis of 
proglycogen content. Glycogen was hydrolysed by the addition of 1mL of 1 
M HCl to the proglycogen and macroglycogen fraction. The sample tubes 
were sealed and heated to 100ºC in a water bath for 2 hours, after which 
they were transferred to Eppendorf tubes and stored at -80ºC until 
fluorometrically analysed for glycosyl units (Lowry & Passoneau, 1973).  
 
3.3.5  Glucose, glucose-6-phosphate and lactate (paper IV) 
Glucose and glucose-6-phosphate were analysed fluorometrically (Lowry & 
Passoneau, 1973) and lactate was analysed using a lactate kit (EnzyPlus, 
Biocontrol System, Denmark).  
 
3.3.6  Muscle fibre characteristics (Paper III) 
The muscle sample was mounted on embedding medium (OCT 
compound) and serial transverse sections (10 µm) were cut in a cryostat 
(2800 Frigocut E, Reichert-Jung, Leica Microsystems GmbH) at -20ºC. 
Myofibrillar ATPase staining with pre-incubation at pH 4.3, 4.6 and 10.3 
was used to identify fibre types I, IIA, IIB (Brooke & Kaiser, 1970) in all 
muscles. In m. biceps femoris and m. longissimus dorsi immunohistochemical 
methods were also used. Serial sections were reacted with myosin heavy 
chain (MHC) antibodies BA-D5 (MHCI) (gift from E.Barrey) and A4-74 
(MHCIIA + MHCIIX) (Alexis Biochemicals). The secondary antibody 
(rabbit anti-mouse immunoglobulins) and the peroxidase-anti-peroxidase 
complex used to visualise the binding to the antibody were obtained from   31 
Dako in Denmark. Sections (containing at least 200 fibres) of the pH 4.6 
ATPase stain were photographed and type IIB fibres on this section 
corresponding to fibres that stained with the A4-74 antibody were classified 
as type IIAX fibres. All type I fibres from the ATPase stain corresponded to 
type I fibres stained with the antibody BA-D5 (MHCI). The muscle fibres 
stained with the antibody A4-74 were classified as IIAX fibres and some of 
these may be pure IIX and/or IIBX fibres. A computerised image analyser 
(Bio-Rad, Scan Beam, Hadsund, Denmark) was used to evaluate fibre type 
composition, fibre type area and relative fibre type area. Sections of m. biceps 
femoris and m. longissimus dorsi were also stained with the NADH tetrazolium 
reductase method (Novikoff et al., 1961). Oxidative capacity was 
subjectively evaluated from the intensity of the blue staining (30-50 fibres of 
each type) as high (the whole fibre stained), medium (some staining 
apparent, mostly at the cell borders), or low (hardly any staining within the 
cell). A semi quantitative estimate of glycogen content in muscle fibres was 
obtained from sections stained with periodic acid-Schiff (PAS). 
 
3.4  Blood samples (Paper II) 
The blood samples were immediately put on ice until they were centrifuged 
to obtain plasma or serum, which was stored at - 80° C until analysis. 
Plasma lactate concentrations were analysed using the Analox Lactate 
Analyser (Analox Instruments LTD, London W6 0BA, UK). Free fatty acid 
(FFA) concentrations in plasma were analysed using a FFA kit from Wako 
(NEFA C test, Wako Chemicals, GmbH, Neuss, Germany) Glucose 
concentrations in plasma were analysed using a fluorometric technique 
(Lowry & Passonneau, 1973). Insulin concentrations in serum were analysed 
by a radioimmunoassay technique, Pharmacia Insulin RIA 100 and Coat-A-
Count (DPC Los Angeles, USA) at the clinical chemical laboratory.  
 
Figure 6. Photos showing pigs trotting on the treadmill, blood sampling from a jugular 
catheter, and a shower after exercise.    32
3.5  Statistical analyses 
In Papers I, II and IV, a rank sum test was used for comparison of values 
from the carrier and non-carrier pigs. For comparison of the consecutive 
biopsy specimens within carriers or non-carriers, a signed rank test was used. 
In Paper III an unpaired t-test was used for comparison of values from the 
carrier and non-carrier pigs. The level of statistical significance was set at P 
< 0.05. Statistical analyses were carried out using Sigma Stat Statistical 
Software version 11.0 (Aspire Software International, 20448 Charter Oak 
Drive, Ashburn, VA, 20147, USA). 
In Paper II the following statistical model was used for the blood data 
pre- and post-exercise. 
yijt = µ + ai +pij + bt + (ab)jt + eijt 
where µ=overall expectation, ai=(fixed) effect of group i, pij=(random) 
effect of pig j within group i, bt=(fixed) effect of time t, (ab)jt =(fixed) 
interaction effect of group and time, and eijt = (random) residual error. 
Heteroscedastic variation was assumed for the errors with different variances 
for the time levels. Differences between groups were tested with the pig 
variation included, whereas the time and interaction effects were tested 
considering the error variation only. Proc Mixed of the SAS statistical 
package was used for the numerical evaluations. 
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4  Main results and discussion 
4.1  Glycogen, Proglycogen and Macroglycogen (Papers I-IV) 
4.1.1  Exercise tests  
The carriers of the PRKAG3  mutation had, as expected, higher muscle 
glycogen storage mainly in the macroglycogen fraction compared with the 
non-carriers before exercise, immediately after exercise and 3 h into the 
recovery phase. Furthermore, the carriers had higher macroglycogen 
content immediately after exercise and 3 h and 6 h into the recovery phase 
after a training period. A similar degradation of glycogen after the exercise 
test before and after the training period took place in both carriers and non-
carriers. A re-synthesis of macroglycogen occurred after 3 h of recovery 
both before and after the training period in the carriers, whereas this was not 
observed in the non-carriers. After 6 h of recovery this difference was no 
longer seen between the genotypes. 
The results from the exercise tests before and after a training period 
confirm the faster re-synthesis of glycogen observed in carriers after exercise 
in a previous study on a few pigs (Essén-Gustavsson et al., 2005). It has also 
been reported that glycogen re-synthesis 2.5 hours after swimming is 
accelerated in transgenic mice (Tg-Prkag3
225Q) expressing the natural pig 
mutation (Barnes et al., 2004). The study on mice suggested that the 
mutation caused a greater reliance on lipid oxidation and that triglyceride 
content in muscle decreased in response to exercise. A study in humans with 
the  γ3  R 2 2 5 W  m u t a t i o n  a l s o  p r o v i d e s  evidence to suggest that the 
PRKAG3 mutation influences not only glycogen metabolism but also lipid 
metabolism. The γ3 R225W mutation in humans causes a 90% increase in 
skeletal glycogen content and a 30% decrease in intramuscular triglyceride 
stores (Costford et al., 2007). Increased lipid oxidation may reduce the   34
demand for glucose oxidation and thus more glucose within the muscle can 
be directed toward glycogen synthesis. 
Several studies have shown that when the total glycogen concentration in 
the muscle reaches a concentration over 300-350 mmol glucosyl units/kg 
dw, the re-synthesis of glycogen occurs mainly in the macroglycogen pool 
in man (Jansson et al., 1981; Adamo et al., 1998). A similar process occurs in 
the carrier pigs, since they showed a higher re-synthesis of macroglycogen 
in early recovery, whereas this was not observed in the non-carriers. As can 
be seen from the results, the re-synthesis of glycogen after 6 h of recovery 
occurred in the proglycogen fraction in both genotypes. In the carrier pigs, 
macroglycogen re-synthesis preceded proglycogen re-synthesis in the early 
recovery phase, possibly due to the higher initial concentration of glycogen. 
 
4.1.2  After euthanasia 
The carriers of the PRKAG3 mutation had higher total glycogen content in 
longissimus dorsi, m. semitendinosus, m. biceps femoris and m. masseter compared 
with the non-carriers. It was the macroglycogen fraction that was higher in 
the muscles. A previous study has shown that the mutation mainly affects 
muscle characteristics of white glycolytic muscles such as m. longissimus dorsi 
and has no effect on red muscles such as m. semispinalis capitis (Lebret et al., 
1999). This is presumably related to the fact that the γ3 isoform of AMPK is 
the predominantly expressed form, especially in muscles containing type IIB 
fibres (Mahlapuu et al., 2004). In agreement with earlier studies on 
untrained pigs, the pigs carrying the PRKAG3 mutation had a higher 
content of glycogen in both m. longissimus dorsi and m. biceps femoris than the 
non-carriers (Enfält et al., 1997; Essén-Gustavsson et al., 2005). Although m. 
masseter is considered to be a red muscle based on high CS activity and low 
glycolytic potential (Monin et al., 1992; Karlström, 1995), the carriers of the 
PRKAG3 mutation had higher macroglycogen content than the non-
carriers. According to the fibre characteristics of the muscle, some glycolytic 
type II fibres exist in m. masseter (Paper III) and they are probably influenced 
by the mutation, resulting in overall higher glycogen content. 
The total glycogen values of the muscles were high after euthanasia, but 
the values are difficult to compare with other studies, since the pigs had 
been training for 5 weeks and training has been shown to increase the 
glycogen content in certain muscles (Essén-Gustavsson et al., 1988). 
Furthermore, in order to avoid a stressful situation, the pigs were euthanised 
with an overdose of pentobarbital through a jugular catheter in their home 
pen by a well-known person and thereafter sampled. In previous studies, the   35 
glycogen content in the carriers has mostly been determined by measuring 
the glycolytic potential. Glycolytic potential estimates the glycogen present 
at slaughter and includes glycogen, as well as lactate, glucose and G-6-P, i.e. 
products and intermediates of post mortem glycolysis (Monin & Sellier, 1985). 
Pre-slaughter handling of the animals affects the glycolytic potential. Both 
glucose and glycogen content are known to be easily affected by stress, 
which means that whether animals were transported and how they are killed 
may have an important impact upon the glycogen levels. For example, it has 
been shown that 0-60% of IIB fibres are depleted after slaughter in an 
abattoir (Karlsson, 1993). This can be compared with the fact that there was 
no depletion pattern after death in the carrier and non-carrier pigs in the 
present study. 
It has been shown that the carriers of the PRKAG3 mutation have 
hyper-accumulation of glycogen and an abnormally enlarged sarcoplasmic 
compartment, mainly in glycolytic muscle fibres (Estrade et al. 1993). Fibres 
that have a high oxidative capacity, such as type I and type IIA fibres, may 
be less affected by the mutation and since carrier pigs have a higher 
macroglycogen content, it is likely that IIB fibres contain more 
macroglycogen.  
According to studies separating glycogen by electrophoresis and by 
transmission electron microscopy (Skurat et al., 1997; Marchand et al., 
2002), the proglycogen and macroglycogen may not represent two distinct 
fractions, but merely subfractions of a continuous distribution of sizes of 
glycogen particles. It is important to bear in mind that the glycogen content 
in the present study was measured in a sample that represented the whole 
muscle, whereas previous studies have shown that glycogen is not 
consistently distributed within the cell (Fridén et al., 1989; Marchand et al., 
2002). In human skeletal muscle, the type and duration of exercise have 
been shown to have implications for where glycogen degradation occurs 
within the muscle fibre (Fridén et al., 1989). For example, the sarcolemmal 
glycogen fraction in type II fibres is depleted during short-term high 
intensity exercise, whereas it remains largely unaffected in type I fibres 
during long-term aerobic exercise. Aerobic exercise primarily results in 
degradation of glycogen from the intramyofibrillar regions within the 
muscle fibres (Fridén et al., 1985; Fridén et al., 1989). Different subcellular 
location of proglycogen and macroglycogen within the muscle cell could 
result in different susceptibility to enzymes such as glycogen synthase and 
glycogen phosphorylase. The degree of activation of AMPK is shown to be 
inversely related to glycogen concentration (Richter et al., 2001; 
Hargreaves, 2004) and it has also been shown that AMPK may be able to   36
sense the status of the cellular energy reserves in the form of glycogen, as it 
has a glycogen-binding domain (McBride et al., 2009). One may speculate 
that the structure and localisation of the glycosomes may differ between 
genotypes and that this is a factor to consider for the degree of AMPK 
activation in association with exercise. 
 
4.1.3  Exercise performance  
Studies of humans with a spontaneous PRKAG3 mutation and transgenic 
mice expressing the PRKAG3 mutation have indicated that the mutation 
results in improved performance in mice and humans (Barnes et al., 2005; 
Crawford et al., 2010). Investigating this phenomenon in trained pigs with 
the natural mutation did not result in the same conclusion. Instead, the 
results were more in agreement with a previous study on a few untrained 
carrier pigs (Essén-Gustavsson et al., 2005). There were great individual 
differences both between and among carriers and non-carrier pigs in terms 
of time until exhaustion and the carriers did not perform better than the 
non-carriers. By thoroughly scrutinising human and transgenic mouse 
studies of the PRKAG3 mutation, it was found that the training protocols in 
the different studies were not comparable to the distance test performed in 
present study. The human study was more of a strength training (leg 
extensions of quadriceps muscles) than endurance training character. 
Furthermore, the study with transgenic mice (Tg-Prkag3
225Q) was conducted 
by repeated electrical stimulation of an isolated muscle, m. extensor digitorum 
longus. This is quite different from treadmill running in vivo, especially since 
rodent muscles are usually composed of only one fibre type (in this case 
white fast-twitch), which is easy to stimulate electrically.  
 
4.2  Effect on insulin and/or contraction induced signalling 
pathways (Papers I, II) 
4.2.1  Before exercise training  
It was demonstrated that increased glycogen synthesis in pigs carrying the 
PRKAG3 mutation is related to an increased exercise-mediated Akt Ser
473 
dependent signalling response in skeletal muscle and increased 
phosphorylation of AS160 compared with non-carriers. The enhanced 
phosphorylation of Akt and AS160 observed in carriers of the PRKAG3 
mutation after treadmill exercise supports exercise-stimulated signalling, 
which may result in an increased glucose influx into the skeletal muscle   37 
cells. Phosphorylation of GSK3α or GSK3β did not differ between the two 
genotypes, nor did the expression of GS or the percentage of active to total 
form of GS activity. Previous studies have shown that phosphorylation of 
Akt activates GSK3, which then influences GS activity and glycogen 
synthesis (Cross et al., 1995). In pigs, this signalling system did not seem to 
be affected by the mutation or acute exercise on a treadmill. The GS 
enzyme activity at rest has been investigated in m. longissimus dorsi of pigs 
carrying the PRKAG3 mutation by Estrade et al. (1994). The study found 
no significant differences between the two genotypes, but showed that the 
branching enzyme activity was twice as high in the muscles, whereas no 
differences were seen regarding the phosphorylase or debranching enzyme 
activity.  
To determine the functional role of the AMPK γ3 isoform, Tg-Prkag3 
225Q  mice have been created. The mice show elevated skeletal muscle 
glycogen content, normal glycogenolysis during exercise and accelerated 
glycogenesis after exercise, increased intramyocellular triglyceride utilisation 
during exercise, increased phosphorylation of acetyl-CoA carboxylase 
(ACC) immediately after exercise but not in recovery, and a reduction in 
phosphorylation of glycogen synthase during recovery. In the Tg-Prkag3
225Q 
mice, the mutation seems to protect against diet induced insulin resistance 
by attenuating intramyocellular triglyceride accumulation (Barnes et al., 
2004).  
A study on humans with the γ3 R225W mutation also provides evidence 
that the PRKAG3 mutation (R225W) influences not only glycogen 
metabolism but also lipid metabolism. The γ3 R225W mutation in humans 
leads to a 90 % increase in skeletal glycogen content and a 30 % decrease in 
intramuscular triglyceride stores (Costford et al., 2007). Increased lipid 
oxidation may reduce the need for glucose oxidation and thus more glucose 
within the muscle can be directed toward glycogen synthesis.  
The PRKAG3 mutation in pigs has previously been suggested to be a 
gain-of-function mutation, leading to increased glucose transport and 
glycogen synthesis (Milan et al., 2000). It has been shown that AMPK 
activity in resting muscle extracts of pigs is about three-fold lower in carriers 
than in non-carriers, both in the presence and absence of AMP (Milan et al., 
2000). Interestingly in the present study there was a tendency for the carriers 
to have a lower expression of AMPK, which may indicate that the 
PRKAG3 mutation has an influence on AMPK.   38
4.2.2  After exercise training  
Carriers of the PRKAG3  mutation which were exercise-trained for five 
weeks had lowered expression of AMPK and increased phosphorylation of 
Akt Ser
473 after exercise compared with non-carriers. Acute exercise 
stimulated the phosphorylation of AS160 in both genotypes, and the 
phosphorylation of GSK3αSer
21  and ACC Ser79 in the non-carriers. An 
increase in pAkt Ser
473 due to exercise is in agreement with exercise studies 
on humans (Sakamoto et al., 2004) and rats (Sakamoto et al., 2003) and was 
also observed in untrained carriers (Paper I). A point of interest is that when 
pAkt Ser
473 values after exercise were high in trained carriers of the 
PRKAG3 mutation, the muscle glycogen storage was also high. This has 
also been shown in a study on humans, in which pAkt Ser
473 was elevated 
more post resistance exercise when subjects had been on a high-
carbohydrate diet causing high muscle glycogen levels in comparison with a 
low carbohydrate diet causing low muscle glycogen levels (Creer et al., 
2005). The trained non-carriers in the present study only had a tendency for 
higher pAkt Ser
473 values after exercise and they had lower muscle glycogen 
levels. The increased signalling response of Akt after exercise observed in the 
trained carriers and the increase in pAS160 may be related to an increased 
glucose influx directed towards glycogen synthesis in the recovery period. 
However, the differences seen between genotypes in pAMPK Thr
172 and 
AMPK expression indicate that altered AMPK activation may play a role for 
the enhanced glycogen storage in the carriers. The lowered AMPK activity 
which has been shown in carrier pigs is likely to reflect feedback inhibition 
due to the high energy status in the muscle (Milan et al., 2000). The lower 
expression of AMPK and pAMPK Thr
172 in the trained carriers may thus be 
related to feedback inhibition by the enhanced glycogen stores. When there 
is a high energy demand in the muscle, AMPK is usually activated in order 
to stimulate glucose uptake and fatty acid oxidation and inhibit glycogen 
synthesis. This was likely to have occurred during the exercise bouts in the 
training period. However, if large glycogen stores are associated with 
AMPK inhibition, glycogen synthesis may be stimulated and not inhibited. 
Indeed, it has been shown that AMPK may sense the status of the cellular 
energy reserves in the form of glycogen, as it has a glycogen binding domain 
(McBride  et al., 2009). The increase in pACC Ser
79 and the pAMPK 
Thr
172/AMPK ratio after exercise in the non-carriers in the present study 
indicates that AMPK was more activated in these pigs. These results from 
the trained non-carriers are in good agreement with findings in human 
exercise studies reporting increases in pAMPK Thr
172  and pACC Ser
79 
concurrent with reductions in muscle glycogen content (Stephens et al.,   39 
2002; Chen et al., 2007). Inhibition of ACC by pAMPK Thr
172 is suggested 
to be an important component in stimulating fatty acid oxidation in 
response to exercise. 
A noteworthy finding was that after 6 h of recovery from exercise the re-
synthesis of glycogen did not differ between the genotypes, although the 
g l y c o g e n  l e v e l s  a t  t h i s  t i m e  d i f f e red markedly. The altered signalling 
response after exercise in the pigs carrying the PRKAG3 mutation thus 
seems to influence only the initial re-synthesis rate of glycogen.  
 
4.3  Metabolic blood responses (Paper II) 
There was no marked effect on insulin and blood glucose concentrations in 
response to exercise in the trained carriers of the PRKAG3 mutation that 
could be associated with their high capacity to store glycogen. These results 
indicate that glucose uptake and the high glycogen storage capacity in 
muscles of carriers of the PRKAG3 mutation are not related to a different 
insulin response. This is also supported by the results of intravenous glucose 
tolerance tests that were performed in both carriers and non-carriers of the 
PRKAG3 mutation, which showed no difference between the genotypes, 
whether trained or untrained (Granlund et al., unpublished observations). 
The similar lactate response to exercise in both carriers and non-carriers of 
the mutation indicates a similar degree of anaerobic metabolism even if 
initial glycogen levels differed between genotypes. These results are in good 
agreement with the lactate response observed after exercise of untrained 
carriers and non-carriers of the PRKAG3 mutation (Essen-Gustavsson et al., 
2005). Whether fatty acid oxidation differs between genotypes in response 
to exercise or in the recovery period was not evaluated here. There was no 
limitation in availability of fatty acids in blood in the early recovery period. 
Intramuscular triglyceride stores are another source that could release fatty 
acids. Notably, humans with the γ3R225W mutation have increased 
glycogen stores and decreased triglyceride stores (Costford et al., 2007). 
Glycogen synthesis in muscle following exercise could be a result of 
increased fatty acid oxidation leading to a glucose sparing effect that 
promotes glycogen synthesis. Other factors that could influence the re-
synthesis of glycogen after exercise are differences in metabolic properties 
among fibre types, localisation of enzymes and glycogen storage within the 
fibres. 
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4.4  Muscle characteristics (Papers I, III) 
4.4.1    Enzyme activity 
Before exercise training  
At rest, the enzyme activity of HK and phosphorylase was higher in carriers 
but no differences concerning CS, HAD, LDH and GS were observed in m. 
biceps femoris. The activity of HK and phosphorylase was higher in the 
carriers than the non-carriers after exercise and 3 h into the recovery phase.  
In earlier studies, CS and HAD activity has been shown to be increased 
and LDH decreased in a white muscle, m. longissimus dorsi, of pigs carrying 
the PRKAG3 mutation (Estrade et al., 1994; Lebret et al., 1999). In a red 
muscle,  m. semispinalis capitis, the mutation has no influence on enzyme 
activity (Lebret et al., 1999). An earlier study on carriers and non-carriers of 
the PRKAG3 mutation has shown that m. biceps femoris contain 23% type I 
and 77% type II fibres with no differences seen between genotypes (Essén-
Gustavsson  et al., 2005). However, the aforementioned study of m. 
longissimus dorsi showed that the latter muscle is composed of 10% type I and 
90% type II fibres, with no differences between genotypes regarding fibre 
type. Type II fibres primarily express the AMP-kinase γ3 (Mahlapuu et al., 
2004), and thus metabolism in muscles composed of many type II fibres may 
be influenced to a greater extent by the mutation. Interestingly, HK activity 
was significantly higher in the m. biceps femoris of the carriers in the present 
study, as was phosphorylase activity, indicating that these enzymes are 
influenced by the mutation.  
 
After exercise training after euthanasia 
The CS activity was higher in the carriers of the PRKAG3 mutation than in 
the non-carriers only in m. longissimus dorsi, and there was no difference 
between genotypes regarding HAD activity in m. longissimus dorsi,  m. 
semitendinosus or m. biceps femoris. The activity of LDH in m. longissimus dorsi 
and m. semitendinosus was lower in the carriers of the PRKAG3 mutation 
than in the non-carriers. The HK activity was higher in all muscles in the 
carriers and the activity of phosphorylase was higher in m. biceps femoris and 
m. longissimus dorsi in the carriers compared with the non-carriers. 
A noteworthy finding was that the HK activity was significantly higher in 
the carrier pigs in all three muscles sampled, indicating a higher capacity for 
phosphorylation of glucose in the glycogen synthesis pathway. This result 
had already been observed regarding m. biceps femoris in non-trained carriers 
(Paper I). Further evidence that this pathway is affected by the mutation is   41 
supplied by the fact that expression and activity of the UDP-glucose 
pyrophosphorylase of m. longissimus dorsi are up-regulated in pigs carrying 
the PRKAG3 mutation (Hedegaard et al., 2004), and that carriers of the 
mutation also have higher branching enzyme activity in m. longissimus dorsi 
(Estrade  et al., 1994). These data on enzyme activity support that high 
muscle glycogen content due to the PRKAG3 mutation is due to an 
increased synthesis of glycogen. 
The PRKAG3 mutation may also have an effect on glycogenolysis in 
association with high muscle glycogen storage as indicated by the higher 
phosphorylase activity found in both m. longissimus dorsi and m. biceps femoris 
in the carriers. The higher phosphorylase and HK activity observed in m. 
biceps femoris of the exercise-trained carriers is in agreement with results on 
untrained carriers (Paper I). This indicates that the PRKAG3 mutation has a 
great influence on these enzymes and may suggest that carriers of the 
mutation have increased glycogen turnover. In a previous study the HAD 
activity was higher in m. longissimus dorsi (Lebret et al., 1999), but this was 
not seen in any of the muscles in the present study. The CS activity was 
higher in the carriers of the PRKAG3 mutation than in the non-carriers 
only in m. longissimus dorsi, which is in accordance with the study on 
untrained carriers (Lebret et al., 1999). The decreased glycolytic capacity in 
m. longissimus dorsi and m. semitendinosus of the carriers is also in accordance 
with the study on untrained pigs (Lebret et al., 1999).  
 
4.4.2  Fibre characteristics  
No differences between genotypes were seen when fibre type composition 
was evaluated with the myosin ATPase method. However, 
immunohistochemical methods showed that compared with the non-
carriers, the carriers had a higher percentage of type II fibres stained with 
the antibody identifying type IIA and IIX fibres in m. longissimus dorsi and a 
lower percentage of type I I B  f i b r e s  i n  b o t h  m. biceps femoris and m. 
longissimus dorsi. In these muscles the relative area of type IIB fibres was 
lower in carriers than in non-carriers.  
Previous studies of fibre characteristics in m. longissimus dorsi in pigs 
carrying the PRKAG3 mutation indicate that alterations may occur in the 
subgroups of type II fibres (Lebret et al., 1999; Park et al., 2009), which is 
also in agreement with the findings of the present study. A notable feature 
was that the carriers of the PRKAG3 mutation had less IIB fibres, not only 
in m. longissimus dorsi, but also in m. biceps femoris, compared with the non-
carriers. It has previously been indicated that adaptations to training may   42
differ between these muscles (Essén-Gustavsson et al., 1980; Essén-
Gustavsson et al., 1988). Endurance-trained pigs had an increased oxidative 
capacity and a higher glycogen content in m. biceps femoris compared with 
non-trained pigs, but no differences were seen in m. longissimus dorsi and m. 
semitendinosus, muscles considered to be less involved during training on a 
treadmill (Essén-Gustavsson et al., 1980; Essén-Gustavsson et al., 1988). The 
oxidative capacity evaluated by CS activity in the present study for the 
different genotypes did not differ in m. biceps femoris but differed in m. 
longissimus dorsi, which may be related to the different involvement of these 
muscles during locomotion. The results for m. longissimus dorsi were similar 
to earlier results on untrained pigs and indicate that this muscle is not as 
much involved during treadmill exercise and therefore does not have to 
adapt to training. In both genotypes, training adaptations in the fibres of m. 
biceps femoris may have caused a similar oxidative capacity in response to the 
increased energy demand during locomotion. PAS staining showed that 
glycogen was lowered in both genotypes in type I, IIA and some IIB fibres 
in m. biceps femoris after exercise (Paper IV), which indicates that these fibres 
had been recruited. Adaptations to exercise training in this muscle may have 
decreased the effects of the PRKAG3 mutation on muscle metabolic and 
contractile properties. A study with transgenic mice models showed that 
mice with a chronically AMPK-activating mutation caused a shift from fibre 
type IIB to IIA/X fibres, had higher activity of CS and increased hexokinase 
protein expression, regardless of whether these mice had exercised or not 
(Röckl et al., 2007). AMPK signalling was suggested to play an important 
role for transforming skeletal muscle fibre types as well as for increasing 
hexokinase II protein expression and oxidative capacity. These findings are 
in agreement with effects of the PRKAG3  mutation on muscle 
characteristics presented in this thesis, especially in m. longissimus dorsi.  
The carriers had less type IIB fibres in m. longissimus dorsi which indicates 
that one effect of the PRKAG3 mutation may be associated with 
transformation of type IIB towards type IIX and IIA fibres, as carriers also 
had more type IIAX fibres. The muscle fibres that are classified as 
MHCIIAX may be a mixture of pure IIX and/or hybrid IIA+IIX and 
IIX+IIB as the antibody A4-74 identifies both IIA and IIX fibres (Graziotti 
et al., 2001; Fazarinc et al., 2009). Studies in pigs indicate that fibre type 
shifts from type IIB to IIA may occur with training (Essén-Gustavsson et al., 
1993; Pedersen et al., 1998). Oxidative capacity is known to increase with 
training and among fibre types oxidative metabolism is high in type I fibres 
and decreases in the order type I > type IIA > type IIX > type IIB fibres 
(Lefaucheur et al., 2002). Modern pig production has resulted in intensive   43 
selection for increasing muscle yield and lean muscle growth, which has not 
only caused fibre type transformation, but also induced an alteration in 
muscle metabolism towards a more glycolytic and less oxidative fibre type 
(Lefaucher, 2010). In contrast, the PRKAG3 mutation has been shown to 
decrease IIB and increase IIA and IIX mRNA expression (Park et al., 2009), 
which also implies that the genotype promotes a more oxidative phenotype. 
The changes seen in muscle characteristics in carriers of the PRKAG3 
mutation thus resemble those seen whe n  m u s c l e s  i n  p i g s  a d a p t  t o  a n  
increased level of physical activity, independent of contractile activity. This 
is supported by the higher CS activity and the higher oxidative capacity of 
type IIB muscle fibre types according to the NADH-tetrazolium reductase 
staining found in m. longissimus dorsi of the carriers. Studies have shown that 
even large animals such as pigs and llamas express MHCIIB fibres, mostly in 
glycolytic muscles (Lefaucheur et al., 1998; Graziotti et al., 2001). The non-
carriers in the present study showed 47% type IIB fibres in the m. longissimus 
dorsi, which is in good agreement with a previous study in pigs (Lefaucheur 
et al., 2002)  
 
Figure 7. Summary of main results of the thesis. 
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5  Conclusions 
  Expression of AMPK in muscle was lower in pigs carrying the 
PRKAG3 mutation than in non-carriers. The increased rate of 
glycogen synthesis following exercise in carriers was correlated with 
an increased signalling response of Akt and its substrate AS160, and 
a higher activity of hexokinase, indicating an increased glucose 
influx and phosphorylation of glucose, directed towards glycogen 
synthesis 
 
  Alterations in the blood concentrations of insulin, glucose, lactate 
and free fatty acids before and after an exercise test and in the 
recovery phase did not differ between carriers and non-carriers of 
the PRKAG3 mutation. 
 
  Immunohistochemical methods showed that carriers of the 
PRKAG3 mutation had a lower percentage of type IIB fibres in m. 
biceps femoris than non-carriers. In m. longissimus dorsi there was a 
lower percentage of type IIB fibres and a higher percentage of type 
IIAX fibres. In both these muscles the relative area of type IIB fibres 
was lower in carriers than non-carriers. The PRKAG3 mutation 
influences muscle characteristics in exercise-trained pigs and 
promotes a varying degree of oxidative phenotype among muscles 
with different functions. 
 
  Carriers of the PRKAG3 mutation had higher total glycogen 
content in all sampled skeletal muscles than non-carriers, with the 
macroglycogen fraction being higher. At 3 h but not at 6 h of 
recovery following exercise, re-synthesis of glycogen, especially of 
macroglycogen, was higher in carriers than in non-carriers. 
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6   Aspects of future work 
This thesis examined some factors behind the high capacity of pigs with 
PRKAG3 mutation to store and re-synthesise glycogen. Further studies are 
needed to continue this investigation. 
 
  In this thesis, studies have been performed on samples that 
represented the whole muscle. A step towards further knowledge 
would be to determine the degradation and re-synthesis of glycogen 
and its fractions (proglycogen and macroglycogen) within a fibre 
and between different fibre types. This could be achieved by using 
for example a confocal microscope to study subcellular structures 
and their relation to glycogen within the muscle cell. Different 
subcellular locations of proglycogen and macroglycogen within the 
muscle cell could result in different susceptibility to enzymes.  
  The carriers have in this study, showed lower expression of AMPK. 
A step further would be to measure the activity of AMPK and also 
combining immunohistochemistry with ordinary histochemistry, to 
determine if there are differences in the expression of AMPK or 
other signalling proteins such as Akt between fibre types. In this 
study the antibody against AMPK α-subunit has been used. Today 
the antibody against AMPK-γ subunit is available and if it works in 
pigs, the antibody could be of interest to use.  
  Combining conventional histochemistry with 
immunohistochemistry will result in a better understanding of the 
muscle and how it adjusts to different stimuli. In particular 
antibodies that can separate MHCIIA and MHCIIX fibres in carrier 
and non-carrier pigs are of interest. This study clearly shows that 
using fibre typing according to the MHC isoforms results in 
extended knowledge.    48
  A more intense exercise protocol with intervals of trotting to recruit 
more type IIB fibres. An exercise test after 3 h of recovery could 
also be of interest, since the carriers re-synthesise more glycogen at 
this time point. 
  Fat is another important energy source. There are studies in humans 
with the γ3 R225W mutation and transgene mice (Tg-Prkag3
225Q) 
which indicate that the PRKAG3  mutation could be associated 
with increased lipid oxidation and in the presence of increased lipid 
supply attenuate the expected accumulation of intramuscular 
triglyceride content. It would therefore be of interest to investigate 
the intramuscular triglyceride content in carriers of the PRKAG3 
mutation and also in relation to different diets.  
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7  Populärvetenskaplig sammanfattning 
Ett flertal grisar av Hampshire ursprung har den dominanta RN mutationen 
vilket medför att dessa grisar har ett nästan fördubblat glykogeninnehåll i sin 
muskulatur. Mekanismen bakom det höga glykogeninnehållet är inte känt 
men mutationen har visat sig vara ett enkelt basparsbyte i PRKAG3 genen. 
Mutationen leder till en förändring i enzymet AMP kinas som medverkar i 
regleringen av glukosomsättningen vid metabolisk stress. Glukos 
transporteras in i cellen med hjälp av bl.a. insulin och lagras till stor del som 
glykogen i skelettmuskulaturen. Glukosmolekylen kan inte diffundera fritt in 
i cellen utan behöver hjälp av transportproteiner. Muskel och fettväv 
uttrycker en speciell glukostransportör, GLUT4, som i basalt tillstånd 
återfinns inuti själva cellen. Med hjälp av speciella signaleringssystem 
förflyttas GLUT4 till plasmamembranet och gör det möjligt för glukos att 
passera cellmembranet och komma in i cellen. Signalering till GLUT4 kan 
ske via hormonet insulin men även medieras av fysisk aktivitet. Glykogen är 
ett viktigt substrat som utnyttjas för energiproduktion i samband med 
muskelarbete och vid slakt är muskulaturens innehåll av glykogen en viktig 
faktor som påverkar köttkvaliteten. Det finns olika former av glykogen (pro- 
och makroglykogen) som anses ha olika funktion och reglering i 
muskulaturen. Nedbrytning och återuppbyggning av pro- och 
makroglykogen sker på olika sätt i samband med muskelarbete. Målsättning 
med detta arbete var att studera skillnader mellan bärare och icke bärare av 
PRKAG3 mutationen när det gäller fibertyper, enzymprofiler, resyntes av 
glykogen(pro- och makroglykogen) efter arbete på rullmatta och uttryck 
och fosforylering (aktivering) av signalproteiner involverade i insulin och 
icke insulin beroende glukosupptag. Grisar som var bärare eller inte bärare 
av mutationen utförde standardiserade fysiska arbeten på rullmatta före och 
efter en träningsperiod. Muskelprover (m. biceps femoris) och blodprover togs 
före och efter arbete samt i återhämtningsfasen. Vävnadsprover från m.   50
masseter,  m. biceps femoris, m. semitendinosus och m. longissimus dorsi togs 
omedelbart efter avlivning. Bärare av mutationen hade jämfört med icke 
bärare högre glykogeninnehåll i alla provtagna muskler och framförallt var 
makroglykogen fraktionen högre. Efter 3 timmars återhämtning efter arbete 
var resyntesen, särskilt av makroglykogen, högre hos bärarna av mutationen. 
Detta sågs inte efter 6 timmars återhämtning. Det fanns inga skillnader 
mellan bärare och icke bärare när det gällde blodkoncentrationer av insulin, 
glukos, laktat och fria fettsyror efter arbete. Uttrycket av AMP kinas i 
muskeln var lägre hos bärare jämfört med icke bärare. Den ökade 
glykogensyntesen efter arbete kan korreleras med ett ökat Akt 
signaleringssvar och dess substrat AS 160 och högre hexokinasaktivitet, 
vilket tyder på ökat inflöde av glukos och fosforylering av glukos som styrs 
mot glykogensyntes. Immunohistokemiska metoder visade att bärare jämfört 
med icke bärare hade lägre procent typ IIB fibrer i m. biceps femoris . I m. 
longissimus dorsi hade bärare av mutationen en lägre procent typ IIB fibrer än 
icke bärare och dessutom en högre procent typ IIAX fibrer. I båda dessa 
muskler var den relativa arean av typ IIB fibrerna lägre hos bärare än hos 
icke bärare. PRKAG3 mutationen påverkar muskelkaraktäristika hos tränade 
grisar och stimulerar en oxidativ fenotyp i varierad grad i muskler med olika 
funktioner.  
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